Tel Aviv University

Grantee Website Tel Aviv, Israel
Purpose
to advance O-antigen-based Shigella vaccines through to licensure by providing the critical data on immunogenicity linked to efficacy required for immuno-bridging
Division
Global Health
Date
JUNE 2018
Region Served
GLOBAL
Committed Amount
$593,110
Grant Topic
Enteric and Diarrheal Diseases
Duration (Months)
30
Grantee Location
Tel Aviv, Israel

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.